Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 1/20 | 1.00 |
| ▸ | BLM | P54132 | 1/20 | 1.00 |
| ▸ | PMP22 | Q01453 | 1/20 | 1.00 |
| ▸ | GSR | P00390 | 2/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.68 |
| ▸ | GRM8 | O00222 | 2/20 | 0.68 |
| ▸ | GRM6 | O15303 | 2/20 | 0.68 |
| ▸ | GRM7 | Q14831 | 2/20 | 0.68 |
| ▸ | GRM4 | Q14833 | 2/20 | 0.68 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.68 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.68 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.68 |
| ▸ | GRM5 | P41594 | 1/20 | 0.68 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.68 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.68 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.68 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.68 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.68 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glutamine SCHEMBL31436292 | 1.00 | KMT2A (1.00) | KMT2AALOX15BLMPMP22GSR | |
| Glutamine SCHEMBL711605 | 1.00 | KMT2A (1.00) | KMT2AALOX15BLMPMP22GSR | |
| Glutamine SCHEMBL7452 | 1.00 | KMT2A (1.00) | KMT2AALOX15BLMPMP22GSR | |
| Glutamine SCHEMBL411575 | 1.00 | KMT2A (1.00) | KMT2AALOX15BLMPMP22GSR | |
| Glutamine SCHEMBL5580393 | 1.00 | KMT2A (1.00) | KMT2AALOX15BLMPMP22GSR | |
| Glutamine SCHEMBL7453 | 1.00 | KMT2A (1.00) | KMT2AALOX15BLMPMP22GSR | |
| Glutamine SCHEMBL994966 | 1.00 | KMT2A (1.00) | KMT2AALOX15BLMPMP22GSR | |
| Glutamine SCHEMBL411588 | 1.00 | KMT2A (1.00) | KMT2AALOX15BLMPMP22GSR | |
| Glutamine SCHEMBL1332116 | 1.00 | KMT2A (1.00) | KMT2AALOX15BLMPMP22GSR | |
| Glutamine SCHEMBL31619675 | 1.00 | KMT2A (1.00) | KMT2AALOX15BLMPMP22GSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 394 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024128542-A1 | CUTTING OIL COMPOSITION | 와이씨켐 주식회사 | 2024-06-20 | — | — | WO | claimed |
| US-20210045383-A1 | ORGANIC METABOLITE COMPOSITIONS AND METHODS OF USE AS MITICIDES FOR HONEY BEES | NIEMCZURA PAUL (US) | 2021-02-18 | — | — | US | claimed |
| WO-2019178141-A1 | ORGANIC METABOLITE COMPOSITIONS AND METHODS OF USE AS MITICIDES FOR HONEY BEES | NIEMCZURA PAUL (US) | 2019-09-19 | — | — | WO | claimed |
| US-20040175411-A1 | Method of treating influenza | VANMOOR ARTHUR | 2004-09-09 | — | — | US | claimed |
| US-20040176453-A1 | Method of treating time-dependent changes in human subjects | VANMOOR ARTHUR (US) | 2004-09-09 | — | — | US | claimed |
| US-20040176454-A1 | Method of treating an infection | VANMOOR ARTHUR (US) | 2004-09-09 | — | — | US | claimed |
| US-20040162350-A1 | Method of treating a non-cancerous disease of the male prostate | VANMOOR ARTHUR (US) | 2004-08-19 | — | — | US | claimed |
| US-6642272-B1 | Enhances the effectiveness of the human immune system by administering an amino acid amide | VANMOOR ARTHUR (US) | 2003-11-04 | — | — | US | claimed |
| US-20240307284-A1 | EMULSION COMPOSITION AND PRODUCTION METHOD THEREOF | AJINOMOTO CO., INC. (JP) | 2024-09-19 | — | — | US | disclosed |
| CN-118304391-A | Application of tumor neoantigen DNA vaccine and Glutamine combined anti-tumor | 上海南方模式生物科技股份有限公司 | 2024-07-09 | — | — | CN | disclosed |
| US-20240215891-A1 | Bio-Electrode Composition, Bio-Electrode, And Method For Manufacturing Bio-Electrode | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-07-04 | — | — | US | disclosed |
| US-20240215890-A1 | Bio-Electrode, Bio-Electrode Composition, And Method For Manufacturing Bio-Electrode | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-07-04 | — | — | US | disclosed |
| US-20240207458-A1 | TARGETED ALPHA PARTICLE THERAPY FOR SOMATOSTATIN RECEPTOR 2 POSITIVE NEUROENDOCRINE TUMORS AND METASTASES | WAKE FOREST UNIVERSITY | 2024-06-27 | — | — | US | disclosed |
| WO-2024126770-A1 | VANADIUM COMPLEXES WITH NITROGEN AND OXYGEN DONOR ATOMS | BORCHERS GMBH (DE) | 2024-06-20 | — | — | WO | disclosed |
| EP-1337604-A1 | REDUCING UNDESIRED POLYMERIZATION IN HYDROCARBON CRACKING PROCESSES | ONDEO NALCO ENERGY SERVICES, L.P. (US) | 2003-08-27 | — | — | EP | disclosed |
| WO-2002036715-A1 | REDUCING UNDESIRED POLYMERIZATION IN HYDROCARBON CRACKING PROCESSES | ONDEO NALCO ENERGY SERVICES, L.P. (US) | 2002-05-10 | — | — | WO | disclosed |
| US-6372121-B1 | ALPHA-AMINO ACIDS, ESTERS, AMIDES OR SALTS OR MERCAPTOACETIC ACID OR ESTER WHICH CONVERT CARBONYL COMPOUNDS TO STABLE WATER SOLUBLE DERIVATIVES | NALCO/EXXON ENERGY CHEMICALS, L.P. | 2002-04-16 | — | — | US | disclosed |
| US-6103822-A | A HYDROPHILIC AND WATER BORNE POLYURETHANES FORMED FROM THE REACTION OF POLYMERIC ACID FUNCTIONAL POLYOLS WITH POLYISOCYANATES | INOLEX INVESTMENT CORPORATION (US) | 2000-08-15 | — | — | US | disclosed |
| EP-1013693-A1 | Polymeric acid funtional polyols, polyurethanes and method for making same | INOLEX INVESTMENT CORPORATION (US) | 2000-06-28 | — | — | EP | disclosed |
| US-5880250-A | FOR PREPARATION OF HYDROPHILIC POLYURETHANE FOAMS | INOLEX INVESTMENT CORPORATION (US) | 1999-03-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240207458-A1 | TARGETED ALPHA PARTICLE THERAPY FOR SOMATOSTATIN RECEPTOR 2 POSITIVE NEUROENDOCRINE TUMORS AND METASTASES | SSTR2, SSTR1, SSTR5 | KMT2A 2558/4885ALOX15 4206/4885BLM 4717/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.